-
Translate Bio Announces Proposed Public Offering of Common Stock
-
Translate Bio (TBIO) PT Raised to $30 at Roth Capital, Following Collaboration Exnpansion With Sanofi
-
UPDATE: Roth Capital Starts Translate Bio (TBIO) at Buy

